Inactief instrument

Andere talen Growblox Sciences Inc Other OTC

Aandelen

US3998471029

slotkoers Other OTC Andere beurzen
- ^USD	-

02/07	GB Sciences, Inc. tekent intentieverklaring voor een licentie om hun op Cannabinoïden gebaseerde Parkinson-formulering te ontwikkelen en op de markt te brengen met Endopure Life Sciences	CI
21/06	GB Sciences, Inc. en EndoPure Life Sciences, LLC gaan een niet juridisch bindende intentieverklaring aan om te onderhandelen en een licentieovereenkomst aan te gaan	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

GB Sciences, Inc Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson?s Formulation With Endopure Life Sciences	02/07
GB Sciences, Inc. and EndoPure Life Sciences, LLC Enter into A Non-Legally Binding Letter of Intent to Negotiate and Enter into A License Agreement	21/06
GB Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02
GB Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	20/11
GB Sciences, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	14-08-23
GB Sciences, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	14-07-23
GB Sciences, Inc. Auditor Raises 'Going Concern' Doubt	14-07-23
Gb Sciences' First-In-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study At the University of Lethbridge	11-07-23
GB Sciences, Inc. announced a financing transaction	30-06-23
GB SCIENCES INC : Change in Directors or Principal Officers (form 8-K)	14-04-23
GB Sciences, Inc. Announces Executive Changes	14-04-23
GB SCIENCES INC : Submission of Matters to a Vote of Security Holders (form 8-K)	10-03-23
GB SCIENCES INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	03-02-23
GB Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	03-02-23
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform	22-12-22
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform	22-12-22
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations	12-12-22
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations	12-12-22
GB SCIENCES INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	09-11-22
GB Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	09-11-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Growblox Sciences Inc Other OTC

Aandelen

US3998471029

Andere talen

Filters